Our mission: develop first-in-class medications that will significantly impact the lives of patients with autoimmune disorders, chronic inflammatory diseases, and cancer.
Athos stands for:
Led by a world class management and advisory team with complementary expertise in the pathobiology of autoimmune diseases, computational biology, medicinal chemistry, drug development, clinical trial design, and regulatory strategy. We believe the solution to complex diseases requires a system based approach.
Athos Therapeutics is led by a world-class management team with a strong pharma, business and academic record in therapeutic drug development.
Scientific Advisory Board
The Athos Therapeutics Scientific Advisory Board (SAB) is comprised of an unrivaled, international group of world-renowned leaders who are experts in the fields of immunology, inflammatory bowel diseases, drug discovery and development. They are providing strategic and scientific advice to the Athos management team in order to guide the development of our innovative therapeutic programs for autoimmune diseases.